|
|
Article: N-Gene Research Laboratories, Inc. Reports Positive Phase II Results With BGP-15 Insulin Sensitizer.
- Article from:
- PR Newswire
- Article date:
- June 12, 2006
CopyrightCOPYRIGHT 2006 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
- Significant Improvement Seen in Insulin Sensitivity -
NEW YORK, June 12 /PRNewswire/ -- N-Gene Research Laboratories, Inc., a privately held biopharmaceutical company developing products to treat insulin resistance, today presented positive Phase II data for BGP-15, a novel insulin sensitizer. The data were presented in a poster presentation at the American Diabetes Association 66th Scientific Sessions conference in Washington, DC, titled "BGP-15, a Novel Insulin Sensitizer." Presenters included Jesse Roth, M.D., Professor of Medicine, Albert Einstein College of Medicine, former Scientific Director of National Institute of Diabetes and Digestive and Kidney ...